Neurocrine Biosciences NBIX
NASDAQ NBIX
$155.08 -0.46 (-0.30%)
At close: Aug 20, 2026 · 11:50 AM UTC

Neurocrine Biosciences (NBIX) EBT Margin (2010 - 2026)

Neurocrine Biosciences (NBIX) posted quarterly EBT Margin of 16.91% for Q2 2026, down 629.0% year-over-year from 3.2% in Q2 2025, and down 44.18% on a QoQ basis from 30.3% in Q1 2026.

Neurocrine Biosciences (NBIX) EBT Margin (2010 - 2026) Analysis & Trends

Neurocrine Biosciences has reported EBT Margin for 16 years, with the latest figure at 16.91% in Q2 2026.

  • EBT Margin for Q2 2026 came in at 16.91%, down 629.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 27.87% (up 687.0% YoY), and the FY2025 annual result was 24.66%, up 403.0% from the prior year.
  • EBT Margin slipped to 16.91% in Q2 2026, from 30.3% in the prior quarter.
  • Over five years, EBT Margin peaked at 38.47% in Q4 2023 and troughed at 116.5% in Q2 2022.
  • A 5-year average of 12.64% and a median of 24.22% in 2022 frame the typical range for EBT Margin.
  • The widest annual swing landed in 2022, when EBT Margin sank 13640 bps; it then jumped 14336 bps in 2023.
  • A 5-year view of EBT Margin shows it stood at 28.62% in 2022, then soared by 34 bps to 38.47% in 2023, then sank by 33 bps to 25.9% in 2024, then grew by 15 bps to 29.72% in 2025, then tumbled by 43 bps to 16.91% in 2026.
  • Per Business Quant data, the three most recent EBT Margin figures were 16.91% in Q2 2026, 30.3% in Q1 2026, and 29.72% in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Haleon 44.07 Bn 43.10 Bn - -
2 Teva Pharmaceutical Industries 43.42 Bn 39.76 Bn 2.15 Bn -10.99%
3 Zoetis 31.86 Bn 30.18 Bn 1.05 Bn 35.09%
4 Takeda Pharmaceutical 28.77 Bn 22.98 Bn 5.10 Bn 13.34%
5 United Therapeutics 22.29 Bn 19.63 Bn 683.80 Mn 47.58%
6 Viatris 18.78 Bn 17.89 Bn 1.46 Bn -1.70%
7 Neurocrine Biosciences 15.66 Bn 15.27 Bn 935.80 Mn 16.91%
8 Elanco Animal Health 11.91 Bn 11.38 Bn 798.00 Mn 4.09%
9 Dr Reddys Laboratories 10.16 Bn 10.00 Bn - -
10 Alkermes 8.20 Bn 7.55 Bn 397.90 Mn -0.38%

Historic Data

Download Data
DateValue
Jun 30, 2026 16.91%
Mar 31, 2026 30.30%
Dec 31, 2025 29.72%
Sep 30, 2025 36.71%
Jun 30, 2025 23.20%
Mar 31, 2025 2.57%
Dec 31, 2024 25.90%
Sep 30, 2024 30.59%
Jun 30, 2024 16.71%
Mar 31, 2024 6.70%
Dec 31, 2023 38.47%
Sep 30, 2023 23.18%
Jun 30, 2023 26.86%
Mar 31, 2023 -24.57%
Dec 31, 2022 28.62%
Sep 30, 2022 25.24%
Jun 30, 2022 -116.50%
Mar 31, 2022 6.89%
Dec 31, 2021 -4.42%
Sep 30, 2021 10.30%